flaviviru
diseas
dengu
fever
denv
west
nile
viru
wnv
zika
yellow
fever
repres
substanti
global
public
health
concern
preexist
chronic
condit
cardiovascular
diseas
diabet
obes
asthma
thought
predict
risk
progress
sever
infect
aim
quantifi
frequenc
chronic
comorbid
flaviviru
diseas
provid
estim
preval
sever
nonsever
infect
examin
whether
chronic
diseas
contribut
increas
risk
sever
viral
express
conduct
comprehens
search
pubm
ovid
medlin
r
embas
embas
classic
grey
literatur
databas
identifi
studi
report
preval
estim
comorbid
flaviviru
diseas
studi
qualiti
assess
risk
bia
tool
ageadjust
odd
ratio
or
estim
sever
infect
presenc
chronic
comorbid
identifi
studi
elig
inclus
denv
studi
wnv
studi
obes
overweight
ie
bmi
kgm
preval
ci
hypertens
diabet
preval
comorbid
denv
howev
hypertens
diabet
heart
diseas
preval
wnv
flavivirida
larg
famili
positivestrand
rna
virus
compris
four
genera
flaviviru
pegiviru
pestiviru
hepaciviru
flaviviru
genu
consist
virus
mani
arthropodborn
human
pathogen
caus
varieti
clinic
diseas
rang
asymptomat
mild
fever
sever
diseas
includ
enceph
hemorrhag
fever
flavivirus
transmit
bite
infect
arthropod
vector
mainli
aed
genu
aed
aegypti
lesser
extent
aed
albopictu
cluex
mosquito
maintain
anim
reservoir
sylvat
transmiss
cycl
mani
flavivirus
howev
dengu
viru
yellow
fever
zika
viru
princip
maintain
mosquitoborn
transmiss
possibl
humantohuman
transmiss
transfus
infect
blood
transplant
infect
tissu
flavivirus
caus
global
signific
vectorborn
diseas
substanti
public
health
impact
dengu
viru
denv
japanes
enceph
viru
jev
west
nile
viru
wnv
zika
viru
zikv
yellow
fever
viru
yfv
member
flavivirida
famili
region
impact
includ
murray
valley
enceph
viru
mvev
oceania
st
loui
enceph
viru
slev
north
america
tickborn
enceph
viru
tbev
europ
past
decad
mani
flavivirus
reemerg
rang
reason
includ
decreas
mosquito
control
effort
rapid
chang
climat
vector
demographi
dens
urban
popul
growth
global
increas
transport
trade
activ
exampl
includ
geograph
spread
denv
throughout
tropic
world
jev
throughout
south
asia
australasia
pacif
zikv
south
central
america
yfv
america
invas
wnv
much
north
america
estim
million
denv
infect
per
year
million
manifest
clinic
vari
degre
sever
billion
peopl
countri
risk
infect
similarli
high
incid
rate
symptomat
case
jev
report
past
three
decad
reach
per
year
per
popul
epidem
wave
yfv
project
result
clinic
case
per
year
casefat
rate
rang
wnv
first
appear
northeastern
usa
spread
present
across
much
usa
southern
canada
exampl
cdc
report
case
wnv
hospit
die
develop
world
wnv
incid
like
underestim
due
polit
psycholog
econom
barrier
report
although
human
flaviviru
infect
asymptomat
undifferenti
febril
ill
small
percentag
affect
individu
develop
acut
fever
progress
sever
clinic
manifest
hemorrhag
vascular
leakag
enceph
current
knowledg
hostrel
factor
influenc
pathogenesi
sever
diseas
inadequ
allow
predict
develop
sever
clinic
ill
howev
mechan
etiolog
factor
underli
interindividu
variat
respons
flaviviru
infect
identifi
interact
virusencod
protein
human
innat
immun
pathway
effect
hostcel
surfac
molecul
viru
bind
entri
role
viral
protein
nuclear
local
host
cell
respons
flaviviru
replic
dynam
within
multipl
immun
system
consid
hostpathogen
interact
event
may
regul
viral
virul
attenu
subsequ
diseas
sever
past
year
howev
hostrel
factor
preexist
chronic
condit
eg
cardiovascular
diseas
diabet
obes
asthma
receiv
attent
predictor
increas
risk
progress
sever
flaviviru
infect
recent
studi
rais
proposit
cardiovascular
diseas
stroke
diabet
respiratori
diseas
renal
disord
may
contribut
togeth
old
age
sever
clinic
manifest
dengu
studi
wnv
jev
infect
respons
yfv
vaccin
also
explor
role
chronic
comorbid
prognosi
infect
given
lack
specif
medic
treatment
flaviviru
diseas
effect
public
health
surveil
vectorborn
infect
togeth
continu
vector
control
effort
critic
prevent
infect
howev
elucid
impact
comorbid
sever
diseas
infect
occur
critic
identifi
vulner
popul
effect
intervent
protocol
individuallytailor
clinic
monitor
practic
particularli
target
object
studi
systemat
review
exist
literatur
preval
common
noncommunic
comorbid
relat
cluster
metabol
syndromesassoci
diseas
diabet
mellitu
heart
diseas
hypertens
asthma
stroke
obes
flaviviru
infect
evalu
differ
preval
sever
vs
nonsever
clinic
outcom
infect
identifi
character
associ
comorbid
sever
flaviviru
infect
signific
factor
design
public
health
measur
aim
prevent
sever
outcom
infect
carri
systemat
literatur
search
conform
prefer
report
item
systemat
review
metaanalysi
prisma
guidelin
see
tabl
pubm
ovid
medlin
r
embas
embas
classic
databas
incept
last
week
novemb
novemb
date
search
databas
date
upper
limit
period
consid
grey
literatur
search
also
conduct
american
societi
tropic
medicin
hygien
open
forum
infecti
diseasesinfecti
diseas
societi
america
two
recent
year
use
pico
format
acronym
popul
problem
intervent
exposur
interest
comparison
outcom
research
question
frequenc
chronic
comorbid
flaviviru
infect
sever
flaviviru
infect
associ
higher
preval
comorbid
tabl
search
relat
term
mesh
inclus
exclus
criteria
synonym
shown
tabl
nonenglish
languag
report
exclud
studi
identifi
relev
studi
use
comprehens
fourstep
search
strategi
prisma
fig
ie
identif
ii
screen
iii
elig
iv
inclus
studi
evalu
studi
denv
wnv
two
jev
inclus
see
fig
given
small
number
studi
jev
two
articl
exclud
quantit
analysi
studi
met
inclus
criteria
yfv
zikv
infect
titl
abstract
identifi
studi
review
independ
two
review
use
covid
systemat
review
softwar
verita
health
innov
melbourn
australia
avail
wwwcovidenceorg
differ
conflict
resolv
third
review
discuss
consensu
reach
percentag
agreement
cohen
kappa
statist
calcul
interpret
accord
landi
koch
benchmark
assess
agreement
review
poor
slight
fair
moder
substanti
excel
methodolog
qualiti
studyfrom
standpoint
evalu
preval
chronic
comorbid
flaviviru
infectionswa
assess
part
data
extract
modif
use
standard
tool
evalu
report
epidemiolog
studi
chronic
diseas
incid
preval
design
assess
populationbas
preval
studi
assess
risk
bia
studi
rate
ten
follow
criteria
clearli
state
research
object
distinctli
defin
studi
popul
homogen
studi
subject
eg
age
ethnic
gender
ratio
origin
studi
popul
sampl
size
power
justif
assess
infect
prior
identifi
comorbid
evalu
level
infecti
diseas
sever
relat
frequenc
comorbid
standard
infecti
diseas
assess
across
studi
subject
standard
assess
tabl
keyword
search
relat
term
synonym
popul
individu
flaviviru
infect
sever
nonsever
case
age
group
dengu
fever
yellow
fever
west
nile
viru
zika
japanes
enceph
diabet
hypertens
heart
diseas
includ
cardiovascular
diseas
coronari
arteri
diseas
coronari
vascular
diseas
atrial
fibril
chronic
ischem
heart
diseas
acut
coronari
syndrom
durat
less
month
cardiac
disord
cardiac
heart
failur
congest
cardiac
failur
stroke
obes
asthma
includ
chronic
obstruct
pulmonari
diseas
copd
proportionr
frequenc
least
one
comorbid
percent
comorbid
deathfat
incid
hospit
mortal
mortal
rate
comorbid
across
studi
subject
assess
comorbid
blindli
infecti
diseas
statu
consid
potenti
confound
clear
adjust
statist
analys
criterion
rate
dichotom
ye
low
risk
point
high
risk
point
overal
score
calcul
ad
item
rate
low
risk
thu
higher
score
indic
lower
risk
bia
stronger
method
qualiti
grey
literatur
mainli
confer
abstract
assess
way
requir
inform
unavail
data
extract
select
studi
duplic
two
review
includ
first
author
name
public
date
countri
date
recruit
total
sampl
size
divid
male
femal
age
estim
report
mean
median
midpoint
age
rang
highest
subject
frequenc
procedur
case
identif
type
flaviviru
infect
sever
infect
preval
clinic
manifest
mild
symptom
fever
headach
muscl
pain
rash
malais
togeth
sever
symptom
describ
percentag
comorbid
includ
diabet
type
type
ii
mention
hypertens
heart
diseas
due
small
sampl
size
individu
condit
tabl
denv
wnv
confirm
case
select
studi
infect
identifi
either
rtpcr
elisa
report
review
nation
surveil
chronic
comorbid
either
selfreport
recordbas
allow
differenti
diagnos
infecti
episod
weight
averag
use
calcul
overal
age
sever
case
denv
defin
form
diseas
develop
major
complic
dengu
hemorrhag
fever
dhf
grade
ii
dengu
shock
syndrom
dss
dhf
grade
iii
iv
infect
develop
organ
failur
eg
acut
renal
failur
acut
respiratori
failur
clinic
signific
bleed
case
requir
icu
hospit
andor
fatal
case
sever
case
wnv
defin
develop
wnv
neuroinvas
diseas
case
wn
enceph
wne
wn
mening
wnm
poliomyel
acut
flaccid
paralysi
case
requir
icu
hospit
need
rehabilit
wnvassoci
retinopathi
wnvr
chorioretin
fatal
case
measur
preval
rate
comorbid
extract
proport
percentag
report
select
studi
total
number
flaviviru
case
nonsever
sever
case
public
bia
assess
visual
inspect
funnel
plot
fig
egger
test
also
use
assess
public
bia
tendenc
effect
estim
small
sampl
size
studi
differ
estim
larger
studi
result
egger
test
present
tvalu
p
public
bia
studi
report
comorbid
interest
tabl
signific
egger
test
public
bia
base
p
primari
outcom
measur
evalu
overal
preval
comorbid
flaviviru
infect
estim
stratifi
sever
metaanalys
carri
assess
pool
preval
ci
clinic
symptom
proport
comorbid
total
sever
nonsever
case
infect
metaanalysi
test
conduct
use
comprehens
metaanalysi
softwar
cma
version
englewood
nj
usa
varianc
raw
proport
percentag
pool
base
binari
randomeffect
model
given
popul
heterogen
assum
relationship
comorbid
flaviviru
infect
vari
across
popul
forest
plot
use
illustr
preval
comorbid
flaviviru
infect
select
studi
prior
stratifi
proport
sever
comparison
proport
preval
clinic
symptom
diseas
pool
preval
estim
comorbid
relat
sever
carri
use
chisquar
test
previous
recommend
or
adjust
age
ci
sever
infect
outcom
patient
comorbid
calcul
use
cochranmantelhaenszel
test
previous
describ
statist
test
twosid
conduct
use
spss
statist
version
spss
inc
chicago
assess
heterogen
among
select
studi
carri
use
q
test
inform
presenc
versu
absenc
heterogen
q
test
howev
report
extent
heterogen
inadequ
power
detect
heterogen
among
small
number
studi
identifi
comorbid
therefor
calcul
index
complement
q
test
describ
degre
betweenstudi
heterogen
index
valu
categor
low
moder
substanti
consider
recommend
also
quantifi
true
heterogen
estim
withinstudi
varianc
randomeffect
model
previous
describ
data
gener
analyz
studi
includ
publish
articl
support
inform
file
origin
search
result
articl
select
titl
review
satisfi
select
criteria
tabl
addit
articl
identifi
bibliographi
search
previous
identifi
systemat
review
fig
dedupl
total
origin
titl
select
abstract
review
abstract
review
result
exclus
report
full
text
assess
conduct
remain
articl
least
two
review
result
select
studi
denv
wnv
two
jev
exclud
inclus
see
fig
exclus
criteria
breakdown
agreement
inclus
two
review
weight
ci
substanti
agreement
may
relat
extent
clariti
assess
abstract
report
rate
presenc
comorbid
initi
stage
select
process
studi
identifi
howev
yfv
zikv
infect
exclud
studi
jev
qualiti
remain
studi
involv
set
patient
assess
maximum
qualiti
score
good
score
point
achiev
studi
studi
denv
wnv
studi
score
fair
qualiti
point
studi
denv
wnv
studi
score
low
qualiti
point
includ
studi
denv
wnv
tabl
score
assess
remain
report
grey
literatur
abstract
denv
wnv
report
studi
retrospect
natur
rest
ageand
sexmatch
nest
casecontrol
studi
surveil
report
prospect
studi
studi
wide
variat
sampl
size
rang
five
patient
cohort
like
report
denv
two
occas
ie
chen
et
al
lee
et
al
also
lee
et
al
lee
et
al
avoid
repeat
count
case
studi
cohort
includ
studi
larger
sampl
size
evalu
total
number
subject
analysi
averag
age
studi
case
furthermor
one
studi
report
studi
denv
case
classifi
highli
suggest
wherea
remain
confirm
diagnost
algorithm
report
separ
identifi
small
number
case
case
repres
total
number
evalu
includ
analysi
moreov
one
studi
includ
fatal
case
denv
chikungunya
viru
coinfect
although
case
may
repres
unusu
clinic
popul
includ
report
inclus
number
subject
extrem
small
n
case
hypertens
repres
entir
hypertens
case
examin
studi
estim
relat
size
studi
public
bia
assess
visual
inspect
funnel
plot
fig
egger
test
tabl
funnel
plot
inspect
demonstr
seemingli
nonsymmetr
distribut
effect
size
either
side
pool
estim
suggest
evid
public
bia
result
egger
test
howev
associ
denv
wnv
comorbid
show
p
except
preval
hypertens
denv
heart
diseas
wnv
p
given
assumpt
evid
smallstudi
effect
base
p
previous
report
studi
select
denv
geograph
divers
includ
countri
report
southeast
asia
south
america
eastern
mediterranean
western
pacif
region
wnv
report
howev
unit
state
studi
tabl
wnv
howev
mening
enceph
present
sever
case
repres
highest
preval
sever
condit
obesityoverweight
preval
comorbid
denv
patient
ci
follow
hypertens
ci
diabet
ci
fig
heart
diseas
asthma
stroke
present
denv
case
hand
wnv
case
hypertens
frequent
comorbid
ci
follow
heart
diseas
diabet
stroke
ci
fig
studi
wnv
report
incid
obes
asthma
overal
low
moder
heterogen
among
identifi
studi
case
denv
wnv
stratifi
sever
tabl
higher
preval
p
diabet
heart
diseas
sever
denv
wnv
case
respect
compar
rate
nonsever
diseas
hypertens
howev
preval
sever
case
flaviviru
infect
p
nonsever
case
asthma
obes
examin
denv
none
select
studi
report
preval
wnv
asthma
obes
frequent
p
patient
sever
denv
nonsever
case
frequenc
stroke
assess
one
studi
nonsever
denv
wnv
permit
comparison
sever
nonsever
case
base
differ
preval
comorbid
sever
nonsever
case
denv
wnv
estim
ageadjust
sever
infect
outcom
patient
chronic
comorbid
ci
denv
patient
obesityoverweight
ci
patient
diabet
heart
diseas
ci
ci
patient
hypertens
sever
wnv
patient
diabet
ci
hypertens
ci
tabl
present
studi
evalu
frequenc
comorbid
denv
wnv
exampl
flaviviru
infect
repres
major
global
health
problem
dataset
unavail
jev
zikv
yfv
two
studi
found
satisfi
select
criteria
jev
report
zikv
relat
coexist
infecti
diseas
chikungunya
hiv
gestat
diabet
singl
case
studi
yfv
howev
primarili
evalu
safeti
effect
vaccin
peopl
preexist
chronic
ill
systemat
review
frequenc
comorbid
flaviviru
infect
exist
none
use
metaanalysi
synthes
global
preval
estim
observ
larg
differ
volum
literatur
total
number
patient
evalu
examin
condit
studi
identifi
denv
subject
wnv
patient
almost
select
studi
assess
good
qualiti
score
evalu
report
chronic
diseas
incid
preval
howev
chronic
diseas
clearli
defin
vast
major
studi
either
selfreport
recordbas
allow
differenti
diagnos
infecti
episod
select
report
provid
sampl
size
justif
infecti
diseas
statu
assess
prior
chronic
diseas
score
develop
chronic
diseas
follow
infect
report
select
studi
furthermor
none
select
studi
report
either
denv
wnv
coinfect
one
anoth
moreov
number
studi
provid
inform
statu
one
chronic
diseas
comorbid
patient
addit
assess
chronic
diseas
blindli
evalu
respect
infecti
diseas
statu
factor
meant
select
studi
goodtofair
qualiti
score
made
us
choos
includ
studi
assess
fair
low
qualiti
metaanalysi
attain
comprehens
estim
larger
sampl
size
avoid
bia
exclud
studi
small
effect
geograph
divers
denv
report
compar
wnv
studi
like
reflect
fact
dengu
common
flaviviru
infect
global
transmiss
occur
least
countri
almost
billion
peopl
around
world
wnv
hand
despit
import
caus
human
diseas
worldwid
continu
increas
transmiss
past
year
spread
notabl
lesser
rate
denv
one
studi
select
report
wnv
region
europ
usa
given
repeat
wnv
outbreak
israel
europ
movement
north
america
last
decad
result
sustain
presenc
commun
predict
identifi
limit
set
wnv
studi
region
primarili
affect
clinic
appar
acut
flaviviru
infect
progress
classic
present
mild
fever
headach
muscl
pain
rash
malais
diseasespecif
syndrom
acut
febril
ill
sever
state
hemorrhag
fever
enceph
pool
preval
analysi
clinic
symptom
indic
compar
lower
frequenc
heart
diseas
c
asthma
stroke
e
obesityoverweight
f
dengu
fever
patient
ci
heterogen
analysi
carri
use
q
test
among
studi
variat
index
withinstudi
varianc
randomeffect
model
wnv
denv
known
wnv
infect
commonli
asymptomat
infect
person
clinic
appar
diseas
symptomat
patient
mostli
present
fever
headach
malais
less
commonli
myalgia
rash
neck
pain
arthralgia
hand
patient
infect
denv
asymptomat
major
case
small
proport
may
develop
array
clinic
symptom
rang
mild
flulik
syndrom
fever
skin
rash
headach
myalgia
arthralgia
sever
form
diseas
rash
frequent
denv
wnv
case
accord
classif
system
denv
patient
clinic
classifi
probabl
dengu
dengu
warn
sign
sever
dengu
deviat
classif
system
categor
patient
df
dhf
dss
denv
patient
select
set
studi
present
df
progress
df
sever
clinic
manifest
mostli
unpredict
case
fatal
rate
may
exceed
time
appropri
differenti
therapi
introduc
reduc
impact
diseas
complic
recent
estim
global
burden
dengu
suggest
epidem
mainli
affect
children
young
adult
age
year
old
term
death
year
live
disabl
yld
year
life
lost
yll
disabilityadjust
lifeyear
dali
howev
age
shift
adult
case
sever
denv
comorbid
present
demonstr
sever
report
around
world
see
addit
ageshift
sever
denv
case
incurs
denv
new
world
region
may
influenc
agerel
increas
incid
diseas
advanc
age
hand
long
known
frequent
risk
factor
sever
diseas
outcom
wnv
averag
annual
incid
sever
wnv
case
report
cdc
case
year
old
per
popul
per
year
compar
patient
year
old
introduct
compet
vector
natur
environ
urban
area
togeth
chang
societ
factor
migrat
industri
trade
urban
popul
growth
may
facilit
geograph
expans
flaviviru
diseas
differ
region
world
exampl
includ
expans
denv
caribbean
island
brazil
pacif
island
region
south
asia
wnv
africa
middl
east
europ
north
america
mani
region
vectorborn
diseas
spread
also
experienc
epidemiolog
shift
communic
diseas
noncommunic
disord
primari
caus
morbid
mortal
age
popul
noncommunic
diseas
account
nearli
half
diseas
burden
lowand
middleincom
countri
therefor
flaviviru
diseas
particularli
denv
may
shown
affect
older
adult
age
group
inher
comorbid
present
studi
demonstr
hypertens
diabet
preval
comorbid
denv
wnv
obesityoverweight
heart
diseas
present
respect
denv
wnv
case
although
preval
diabet
hypertens
heart
diseas
vari
wide
among
denv
select
studi
rang
vast
major
report
show
valu
cluster
around
pool
estim
averag
comorbid
evidenc
low
index
valu
obes
stroke
asthma
proport
vari
among
studi
moder
index
valu
howev
wnv
studi
amongstudi
preval
comorbid
vari
diabet
hypertens
heart
diseas
stroke
low
moder
index
variat
preval
comorbid
wnv
case
may
relat
higher
averag
patient
age
compar
denv
sinc
older
age
risk
factor
number
noncommunic
diseas
eg
diabet
heart
condit
hand
wider
variat
preval
comorbid
denv
wnv
link
differ
pattern
geograph
distribut
two
diseas
diabet
hypertens
heart
diseas
respect
significantli
preval
sever
denv
wnv
nonsever
case
observ
support
number
casecontrol
studi
implic
comorbid
sever
outcom
flaviviru
infect
higher
frequenc
diabet
found
sever
denv
case
case
df
furthermor
sever
clinic
present
denv
like
develop
patient
diabet
nondiabet
subject
odd
ratio
rang
ci
ci
line
sever
denv
wnv
observ
among
patient
diabet
heart
diseas
diabet
risk
factor
glucos
intoler
hyperlipidemia
preval
sever
denv
case
respect
frequent
elder
patient
similarli
diabet
hyperlipidemia
coronari
arteri
diseas
preval
wnv
case
control
neuroinvas
outcom
vari
ci
ci
diabet
frequent
case
wne
wnm
wnv
fever
develop
enceph
like
occur
wnv
case
also
diabet
ci
cardiovascular
diseas
ci
furthermor
hypertens
shown
present
sever
fatal
denv
case
manifest
acut
respiratori
failur
higher
proport
elder
patient
vari
ci
ci
contrast
studi
show
relationship
sever
denv
wnv
patient
hypertens
higher
odd
develop
neuroinvas
outcom
ci
enceph
ci
nonhypertens
case
high
preval
hypertens
also
note
patient
wne
wnm
fatal
outcom
compar
wnv
fever
line
find
result
present
studi
strongli
suggest
diabet
heart
diseas
hypertens
preval
sever
denv
wnv
case
nonsever
diseas
may
present
signific
risk
factorstogeth
advanc
agein
complic
flaviviru
infect
diabet
hypertens
cardiac
diseas
obes
interrel
share
similar
cardiometabol
risk
factor
result
develop
metabol
syndrom
subsequ
manifest
rang
chronic
diseas
metabol
syndrom
relat
diseas
may
impair
immun
system
increas
level
durat
viremia
facilit
passag
neurotrop
flaviviru
across
bloodbrain
barrier
predispos
patient
neurolog
complic
impair
innat
immun
systemthat
mediat
host
defens
infectionrend
individu
suscept
rang
infecti
diseas
sever
ill
fact
metabol
syndrom
relat
chronic
condit
link
endotheli
dysfunct
attenu
antiinflammatori
respons
gener
proinflammatori
state
featur
also
common
mani
infecti
disord
overproduct
proinflammatori
cytokin
il
known
occur
sever
denv
wnv
yfv
lead
cytokin
storm
vasculopathi
hemorrhag
tissu
damag
septic
shock
characterist
sever
flaviviru
infect
cytokin
synthesi
shift
microbicid
action
proinflammatori
antiinflammatori
sever
infect
accompani
increas
proinflammatori
cytokin
level
aris
chronic
diseas
lead
endotheli
dysfunct
subsequ
rang
complic
includ
allergi
vascular
leakag
ascit
pericardi
effus
observ
denv
support
mononuclear
cell
diabet
patient
infect
denv
produc
significantli
higher
level
granulocytemacrophag
colonystimul
factor
compar
healthi
counterpart
condit
hyperglycemia
cellular
insulinopenia
may
also
impair
macrophag
lymphocyt
function
lead
statu
reduc
acquir
immun
respons
link
increas
risk
pneumoniarel
complic
hospit
evid
possibl
role
alter
innat
immun
mediat
associ
metabol
syndromerel
comorbid
sever
clinic
present
flaviviru
infect
also
substanti
rel
high
preval
asthma
sever
denv
case
patient
asthma
normal
exhibit
alter
respons
gener
although
etiolog
relationship
chronic
comorbid
sever
flaviviru
diseas
yet
fulli
elucid
may
reason
suggest
infect
patient
chronic
condit
may
synergist
attenu
innat
adapt
immun
system
may
impair
critic
compon
immun
chemotaxi
phagocytosi
bactericid
activ
neutrophil
macrophag
well
downregul
function
cell
neutrophil
exacerb
complic
infecti
diseas
although
present
studi
first
systemat
report
quantifi
preval
comorbid
flaviviru
infect
sever
limit
address
effect
flaviviru
infect
develop
chronic
comorbid
attempt
substanti
causal
two
condit
also
studi
address
effect
integr
vector
manag
practic
infecti
chronic
diseas
incid
causal
associ
simpli
report
preval
comorbid
flaviviru
sever
nonsever
case
warrant
studi
investig
effect
chronic
comorbid
infecti
diseas
outcom
select
studi
mostli
retrospect
natur
variabl
clinic
laboratori
diagnost
criteria
control
group
heterogen
exposur
outcom
denv
studi
although
major
conduct
adopt
new
case
classif
improv
clinic
manag
mani
report
still
use
classif
absenc
similar
endpoint
measur
hinder
result
compar
may
limit
generaliz
conclus
geograph
region
older
age
group
sinc
criteria
base
diseas
pattern
children
thailand
addit
retrospect
natur
mani
identifi
studi
incomplet
clinic
dataset
rel
small
sampl
size
inappropri
definit
select
control
popul
note
shortcom
variou
report
lead
limit
interpret
find
fact
studi
hospitalbas
high
potenti
select
bia
appropri
control
group
addit
studi
retriev
review
measur
differ
outcom
denv
dhf
dsswith
differ
grade
definit
sever
wnv
wne
wnm
poliomyel
acut
flaccid
paralysi
make
result
difficult
compar
broaden
scope
outcom
render
find
challeng
extrapol
furthermor
identifi
report
shown
severalfold
amongstudi
varianc
proport
comorbid
may
contribut
signific
heterogen
observ
report
addit
sourc
heterogen
may
relat
larg
amongstudi
variat
sampl
size
surveil
approach
heterogen
select
studi
evid
public
bia
may
driven
smallstudi
effect
ie
possibl
includ
small
studi
spurious
overst
estim
discount
without
statist
signific
effect
may
lower
possibl
publish
address
howev
stratifi
analysi
flaviviru
infect
includ
studi
relat
research
question
rather
exclud
report
base
lack
qualiti
may
levi
limit
estim
contribut
comorbid
sever
flaviviru
infect
render
result
guid
gener
accur
estim
nation
intern
intervent
strategi
subject
comorbid
assess
comorbid
studi
show
variou
coexist
condit
either
selfreport
recordbas
allow
differenti
diagnos
infecti
episod
furthermor
retriev
report
provid
clearli
character
valid
reliablydefin
comorbid
implement
consist
across
studi
exampl
major
report
distinguish
preval
type
type
diabet
combin
despit
differ
characterist
etiolog
factor
clinic
featur
given
pauciti
inform
challeng
distinguish
two
type
diabet
role
viral
diseas
sever
complic
furthermor
lack
consist
report
status
heart
diseas
made
difficult
evalu
frequenc
heart
condit
therefor
combin
differ
heart
condit
singl
comorbid
util
pool
clinic
differ
heterogen
patholog
heart
diseas
may
lead
lose
signific
observ
result
misinterpret
observ
warrant
develop
rigor
studi
explor
role
variou
heart
condit
sever
flavivir
infect
given
possibl
extent
underdiagnosi
mani
assess
comorbid
particularli
develop
world
misclassif
mani
coexist
medic
condit
like
substanti
togeth
possibl
underestim
frequenc
infecti
diseas
asymptomat
case
detect
factor
may
led
lower
estim
preval
mani
assess
comorbid
lastli
sinc
identifi
two
studi
jev
studi
met
inclus
criteria
yfv
zikv
infect
present
report
may
view
focus
primarili
denv
wnv
lack
avail
inform
preval
comorbid
flaviviru
diseas
denv
wnv
call
develop
largescal
studi
cover
knowledg
gap
conclus
studi
comorbid
flaviviru
infect
import
reduc
burden
diseas
via
guid
approach
improv
patient
outcom
differenti
case
manag
provid
evid
higher
preval
diabet
hypertens
heart
diseas
sever
case
flaviviru
infect
denv
wnv
nonsever
case
find
implic
causal
chronic
comorbid
sever
denv
wnv
simpli
demonstr
differ
profil
comorbid
differ
stage
infecti
diseas
result
warrant
assess
identifi
natur
extent
coexist
comorbid
infect
exampl
standard
prospect
casecontrol
studi
region
high
infect
preval
would
contribut
better
understand
etiolog
role
comorbid
sever
diseas
outcom
conduct
agre
protocol
comorbid
assess
infect
classif
diseas
biomark
analysi
appropri
control
group
howev
even
absenc
causal
infer
noncommunic
infecti
diseas
may
justifi
nonsever
episod
flaviviru
infect
confirm
subject
comorbid
remain
close
surveil
avert
complic
may
guid
public
health
practition
clinician
predict
complicationsat
least
partiallybas
presenc
comorbid
subsequ
substanti
close
observ
adequ
treatment
hospit
follow
infect
avert
sever
diseas
outcom
support
inform
